Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Alving

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Blood|April 1, 1984
L-asparaginase: acute effects on protein synthesis in rabbits with normal and increased fibrinogen productionB M Alving, C F Barr, D B Tang
Blood|January 1, 1996
PAI-1-resistant t-PA: low doses prevent fibrin deposition in rabbits with increased PAI-1 activityC Krishnamurti, B Keyt, P Maglasang, et al.
The American Journal of Medicine|February 1, 1990
Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin timesB M Alving, C F Barr, D B Tang
Thrombosis Research|February 15, 1982
Preparation of beta-XIIa (Hageman factor fragment) from human plasmaD L Tankersley, B M Alving, J S Finlayson
Annals of Internal Medicine|February 24, 2001
Update in hematologyG P Schechter, H P Dave, B M Alving
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa)B M Alving, D L Tankersley, B L Mason
Blood|August 1, 1983
Activation of factor XII by dextran sulfate: the basis for an assay of factor XIID L Tankersley, B M Alving, J S Finlayson
Transfusion|January 1, 1985
Replacement therapy for congenital Factor X deficiencyR D Knight, C F Barr, B M Alving
The American Journal of Medicine|April 1, 1985
Acquired dysfibrinogenemia. Paraneoplastic syndrome in renal cell carcinomaN A Dawson, C F Barr, B M Alving
American Journal of Hematology|September 1, 1996
Severe vitamin K deficiency induced by occult celiac disease BR96-026R A Avery, W E Duncan, B M Alving
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Blood|April 1, 1984
L-asparaginase: acute effects on protein synthesis in rabbits with normal and increased fibrinogen productionB M Alving, C F Barr, D B Tang
Blood|January 1, 1996
PAI-1-resistant t-PA: low doses prevent fibrin deposition in rabbits with increased PAI-1 activityC Krishnamurti, B Keyt, P Maglasang, et al.
The American Journal of Medicine|February 1, 1990
Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin timesB M Alving, C F Barr, D B Tang
Thrombosis Research|February 15, 1982
Preparation of beta-XIIa (Hageman factor fragment) from human plasmaD L Tankersley, B M Alving, J S Finlayson
Annals of Internal Medicine|February 24, 2001
Update in hematologyG P Schechter, H P Dave, B M Alving
The Journal of Laboratory and Clinical Medicine|February 1, 1983
Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa)B M Alving, D L Tankersley, B L Mason
Blood|August 1, 1983
Activation of factor XII by dextran sulfate: the basis for an assay of factor XIID L Tankersley, B M Alving, J S Finlayson
Transfusion|January 1, 1985
Replacement therapy for congenital Factor X deficiencyR D Knight, C F Barr, B M Alving
The American Journal of Medicine|April 1, 1985
Acquired dysfibrinogenemia. Paraneoplastic syndrome in renal cell carcinomaN A Dawson, C F Barr, B M Alving
American Journal of Hematology|September 1, 1996
Severe vitamin K deficiency induced by occult celiac disease BR96-026R A Avery, W E Duncan, B M Alving
Pageof 9